Lifestyle Factors and Non-Pharmacological Interventions in Mild Cognitive Impairment: Implications for Cognitive Health
DOI:
https://doi.org/10.12775/QS.2026.49.67607Keywords
mild cognitive impairment, dementia, cognitive decline prevention, lifestyle-related risk factors, physical activity, exercise interventions, non-pharmacological interventions, ; multidomain lifestyle programAbstract
Background. Mild Cognitive Impairment (MCI) is a heterogeneous clinical syndrome associated with an increased risk of progression to dementia, although individual trajectories vary substantially. Growing evidence indicates that modifiable vascular-metabolic, lifestyle, nutritional, and psychosocial factors influence cognitive outcomes in MCI, and that non-pharmacological interventions (NPIs) may support cognitive performance.
Aim. To synthesize current evidence on modifiable risk factors associated with progression from MCI to dementia and to evaluate the effectiveness of NPIs targeting cognitive outcomes in patients with MCI.
Material and methods. This structured narrative review was based on a targeted search of the PubMed database. Systematic reviews, meta-analyses, longitudinal cohort studies, and randomized controlled trials examining modifiable risk factors and NPIs in MCI were included. Twenty-eight peer-reviewed articles met predefined eligibility criteria and were synthesized narratively.
Results. Cardiometabolic conditions, physical inactivity, depressive symptoms, and suboptimal dietary patterns were consistently associated with increased risk of cognitive decline in MCI. Biomarker-informed studies suggest that modifiable factors remain relevant even in patients with underlying Alzheimer’s disease (AD) pathology. Randomized trials and systematic reviews indicate that structured exercise, cognitive training, dietary interventions, and multidomain lifestyle programs are associated with improved cognitive performance, with evidence of dose–response effects.
Conclusions. An integrated clinical approach combining assessment of modifiable risk factors with targeted NPIs may support cognitive outcomes in patients with MCI and represents a relevant strategy for early preventive care.
References
1. Petersen RC. Mild Cognitive Impairment. Continuum. 2016;22(2):404-418. doi:10.1212/CON.0000000000000313
2. Practice guideline update summary: Mild cognitive impairment [RETIRED]: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018;90(3):126-135. doi:10.1212/WNL.0000000000004826
3. Chen PH, Cheng SJ, Lin HC, Lee CY, Chou CH. Risk Factors for the Progression of Mild Cognitive Impairment in Different Types of Neurodegenerative Disorders. Behavioural Neurology. 2018;2018:1-8. doi:10.1155/2018/6929732
4. Öksüz N, Ghouri R, Taşdelen B, Uludüz D, Özge A. Mild Cognitive Impairment Progression and Alzheimer’s Disease Risk: A Comprehensive Analysis of 3553 Cases over 203 Months. JCM. 2024;13(2):518. doi:10.3390/jcm13020518
5. Perron A, Roussel M, Wannepain-Despretz S, et al. In Individuals With Subjective Cognitive Decline, Age, Memory and Speed Scores at Baseline Predict Progression to Cognitive Impairment. Alzheimer Disease & Associated Disorders. 2022;36(4):359-361. doi:10.1097/WAD.0000000000000520
6. Gao J, Liu L, Yang Z, Fan J, for the Alzheimer’s Disease Neuroimaging Initiative. Predictors of Transition from Mild Cognitive Impairment to Normal Cognition and Dementia. Behavioral Sciences. 2025;15(11):1552. doi:10.3390/bs15111552
7. Cooper C, Sommerlad A, Lyketsos CG, Livingston G. Modifiable Predictors of Dementia in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis. AJP. 2015;172(4):323-334. doi:10.1176/appi.ajp.2014.14070878
8. Jones A, Ali MU, Kenny M, et al. Potentially Modifiable Risk Factors for Dementia and Mild Cognitive Impairment: An Umbrella Review and Meta-Analysis. Dement Geriatr Cogn Disord. 2024;53(2):91-106. doi:10.1159/000536643
9. Baumgart M, Snyder HM, Carrillo MC, Fazio S, Kim H, Johns H. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population‐based perspective. Alzheimer’s & Dementia. 2015;11(6):718-726. doi:10.1016/j.jalz.2015.05.016
10. Assaf G, El Khoury J, Jawhar S, Rahme D. Mild Cognitive Impairment and modifiable risk factors among Lebanese older adults in primary care. Asian Journal of Psychiatry. 2021;65:102828. doi:10.1016/j.ajp.2021.102828
11. Carrarini C, Caraglia N, Quaranta D, et al. Risk factors of dementia in a cohort of individuals with mild cognitive impairment in the Italian Interceptor project. Euro J of Neurology. 2025;32(2):e16591. doi:10.1111/ene.16591
12. Huszár Z, Solomon A, Engh MA, et al. Association of modifiable risk factors with progression to dementia in relation to amyloid and tau pathology. Alz Res Therapy. 2024;16(1):238. doi:10.1186/s13195-024-01602-9
13. Gómez-Soria I, Marin-Puyalto J, Peralta-Marrupe P, Latorre E, Calatayud E. Effects of multi-component non-pharmacological interventions on cognition in participants with mild cognitive impairment: A systematic review and meta-analysis. Archives of Gerontology and Geriatrics. 2022;103:104751. doi:10.1016/j.archger.2022.104751
14. Wang Y yuan, Wang X xian, Chen L, Liu Y, Li Y ru. A systematic review and network meta-analysis comparing various non-pharmacological treatments for older people with mild cognitive impairment. Asian Journal of Psychiatry. 2023;86:103635. doi:10.1016/j.ajp.2023.103635
15. Shao Z, Hu M, Zhang D, et al. Dose‐response relationship in non‐pharmacological interventions for individuals with mild cognitive impairment: A systematic review and meta‐analysis of randomised controlled trials. Journal of Clinical Nursing. 2022;31(23-24):3390-3401. doi:10.1111/jocn.16240
16. Baker LD, Pa JA, Katula JA, et al. Effects of exercise on cognition and Alzheimer’s biomarkers in a randomized controlled trial of adults with mild cognitive impairment: The EXERT study. Alzheimer’s & Dementia. 2025;21(4):e14586. doi:10.1002/alz.14586
17. Montero-Odasso M, Zou G, Speechley M, et al. Effects of Exercise Alone or Combined With Cognitive Training and Vitamin D Supplementation to Improve Cognition in Adults With Mild Cognitive Impairment: A Randomized Clinical Trial. JAMA Netw Open. 2023;6(7):e2324465. doi:10.1001/jamanetworkopen.2023.24465
18. Li PWC, Yu DSF, Siu PM, Wong SCK, Chan BS. Peer-supported exercise intervention for persons with mild cognitive impairment: a waitlist randomised controlled trial (the BRAin Vitality Enhancement trial). Age and Ageing. 2022;51(10):afac213. doi:10.1093/ageing/afac213
19. Ornish D, Madison C, Kivipelto M, et al. Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer’s disease: a randomized, controlled clinical trial. Alz Res Therapy. 2024;16(1):122. doi:10.1186/s13195-024-01482-z
20. Choi HY, Kim YJ, Son DS, Ahn ME, Lee SK. Effectiveness of a 52-week multidomain intervention to maintain cognitive function in patients with mild cognitive impairment: a randomized controlled trial. Sci Rep. 2025;15(1):41141. doi:10.1038/s41598-025-24865-0
21. Tsolaki M, Lazarou E, Kozori M, et al. A Randomized Clinical Trial of Greek High Phenolic Early Harvest Extra Virgin Olive Oil in Mild Cognitive Impairment: The MICOIL Pilot Study. JAD. 2020;78(2):801-817. doi:10.3233/JAD-200405
22. Han HJ, Ko MJ, Park A, Cheun J, Nam Y, Kim TH. Development of a digital multidomain lifestyle intervention for mild cognitive impairment: A pilot study on the feasibility and efficacy of cognitive training. DIGITAL HEALTH. 2024;10:20552076241284810. doi:10.1177/20552076241284810
23. Cardelo MP, Corina A, Leon-Acuña A, et al. Effect of the Mediterranean diet and probiotic supplementation in the management of mild cognitive impairment: Rationale, methods, and baseline characteristics. Frontiers in Nutrition. 2022;Volume 9-2022. doi:https://doi.org/10.3389/fnut.2022.1037842
24. Peters R, Booth A, Rockwood K, Peters J, D’Este C, Anstey KJ. Combining modifiable risk factors and risk of dementia: a systematic review and meta-analysis. BMJ Open. 2019;9(1):e022846. doi:10.1136/bmjopen-2018-022846
25. Katabathula S, Gurney M, Perry G, Davis PB, Xu R. Identifying patients with mild cognitive impairment at high risk of transitioning to Alzheimer’s disease using routinely collected data. Journal of Alzheimer’s Disease. 2025;108(1_suppl). doi:10.1177/13872877251351622
26. Wang W, Peng J, Hou J, et al. Predicting mild cognitive impairment progression to Alzheimer’s disease based on machine learning analysis of cortical morphological features. Aging Clin Exp Res. 2023;35(8):1721-1730. doi:10.1007/s40520-023-02456-1
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Natalia Marianna Kubiś, Bartosz Palacz, Maria Magdalena Teper , Wiktor Perz , Aleksander Polus , Julia Anna Wrona , Anna Gluzicka , Liwia Olczyk , Jędrzej Piotrowski , Anhelina Korolchuk
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 31
Number of citations: 0
